
The pharmaceutical industry has spent the last two years debating whether direct-to-patient pharma business models are real. That debate is over.
James "Jim" Cleffi is a Managing Director with Alvarez & Marsal's Life Sciences Industry Group in Philadelphia. He specializes in transformational strategies focused on business growth, commercial models, M&A and customer strategies, working across the healthcare ecosystem with a focus on growth and stakeholder value.
Mr. Cleffi brings more than 20 years of experience driving high-value transformations oriented towards business growth, operational improvement and distinctive customer capabilities across the globe, advising leading and emerging life sciences companies with an entrepreneurial and deep customer perspective.